Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (14502)	2/4/2005 6:22:55 PM
From: scion	Read Replies (1) \| Respond to of 19428

The MLON repercussions are eliciting some 'true confessions'.. HEE Reports Guidance, Comments on Mellon Research, Inc. --Feb. 4, 2005--The Hee Corporation, Inc. ("HEE") (HCCF on OTC Pink Sheets) On November 9, 2004, HEE Corporation (HCCF.PK) entered into an agreement with Wall Street Group, LLC. Under that Agreement, Wall Street Group, LLC was to provide specific services in the area of public relations, advertising campaigns, preparation of materials for use with the investing public, and other activities designed to improve the value of company stock. That Agreement expires on February 9, 2005. As compensation for that agreement and the services to be provided by Wall Street Group, LLC, they received 8,333,333 shares. Over the next month, Wall Street Group, LLC presented HEE Corporation with additional suggestions and new agreements including one for the private placement of HEE Corp stock. HEE rejected all of those proposals. On December 27, 2004, and after much negotiating, Mellon Research, Inc. asked HEE Corporation to enter into an additional Agreement. HEE Corporation agreed with that proposal and, as compensation for promised services, delivered to Mellon Research, Inc. an additional 35 million shares. Mellon Research, Inc, paid HEE Corporation $100,000.00 in cash and $100,000.00 in Mellon Research, Inc. stock. The cash payment came from undisclosed investors and the stock from Mellon Research, Inc. Mellon was to provide HEE with a CPA experienced in securities and other professionals in order to establish the framework for HEE to become a Bulletin Board Company. In late January 2005, Wall Street Group, LLC asked HEE Corporation to agree to an assignment of their Agreement to Mellon Research, Inc. HEE Corporation decided not to agree to the assignment, took issue with an unauthorized press release of Mellon, and decided to discontinue any further negotiations with Wall Street Group, LLC and Mellon Research, Inc. HEE Corporation fulfilled all its obligations under the Agreement with Wall Street Group, LLC and the Agreement with Mellon Research, Inc. and has no future plans to be involved with either firm. Business Outlook Management offers the following guidance for the quarter ending March 31, 2005: Revenue is expected to begin. Licensing of clinics to represent the HEE Corporation product. Management offers the following guidance for the quarter ending March 31, 2005: Our target for share price is between 3 and 5 cents About HEE Founded in 2004, HEE ("HCCF.PK") is the worldwide leader providing a corporate vehicle for a new and extremely promising nutraceutical for Type II Diabetes. This nutraceutical was developed in India and is currently being tested here in the U.S. Upon the highly successful results of the current testing; HEE is working diligently to get this nutraceutical treatment market ready.